Flyte Aviation Executes Letter of Intent to Sell Cardiology Assets
Proposed Sale to include VIVO and LockeT Cardiac Electrophysiology product lines Divestiture would Complete the Company's Planned Transition to Pure-Play Tech-Enabled Private Aviation The Proposed Sale would result in a Significant Reduction of Operating Expenses Use of Sale Proceeds...
Read the full story on PR Newswire → Opens the original article on www.prnewswire.comSummary aggregated from PR Newswire's public RSS feed. The full reporting belongs to PR Newswire — please read it on their site.